Systematic Review in Patients with Benign Prostatic Hyperplasia for The Role of Prostatic Arterial Embolization

This study aimed at reviewing the role of Prostatic Arterial Embolization (PAE) as a new treatment producer for patients with Benign Prostatic Hyperplasia (BPH). The study reviewed the recent researches of  Prostatic Arterial Embolization (PAE) as a new treatment technique and concluded that the initial reported results of PAE seem promising, mainly during the first 12 months after treatment. However, no comparison was made to medical therapy or surgical therapies. Overlapping patient data and reporting bias could not be excluded. None of the included studies performed a power analysis. Also, a relatively small number of patients are treated with a short follow-up period. Therefore, more studies are needed with more patients and longer periods of follow-up, compared with standard medical and surgical therapies, to assess whether PAE is an effective and safe alternative treatment for BPH

Type 1 and Type 2 Diabetes among Youths in Jordan: Incidence and Trends for the period (2011-2016)

This study aimed at analyzing the incidence of Type 1 and Type 2 diabetes among youths in Jordan for the period (2011-2016), the researchers adopted the survey methodology for the period of five years from the records of the medical centers (public and private) in Jordan. Also investigated the differences between Type 1 and Type 2 diabetes in diagnosis and treatments. Results showed significant upward trend in the incidence of type 1 diabetes was observed overall with considerable variation across demographic subgroups of age, sex. And also showed among youths who were 10 to 19 years of age, unadjusted models revealed significant increases in the incidence of type 2 diabetes with increases observed across all age and sex